RT @GhanaboyPharmd: @ChadDKollas @Caitlin_Jones_ This is a great article i love from the late great Dr. Fudin regarding PK differences betw…
@ChadDKollas @Caitlin_Jones_ This is a great article i love from the late great Dr. Fudin regarding PK differences between oxycontin vs oxycodone https://t.co/7815IDo2tq
@EnGee16 @YoleetahI So sorry for you loss @YoleetahI It will be a process I’m sure to get your bearings. PPC often does tid dosing of OxyContin in our cancer patients, and I do wonder if the bid dosing has contributed to these issues. Here is a perspective
@Lissa74273886 @soofriends @ChristinaKTLA @PamalaTrotter Also OxyContin is one area I feel makers screwed up. They knowingly marketed 8-hr med at best as longer acting. Pts in/out of pain/WDs, docs up dosage then flagged as overprescribing. https://t.co/H5
RT @EricaWegrzyn: Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam
Out in print during @PAINWeek and all authors on site! https://t.co/BNTxnr0jwK
RT @EricaWegrzyn: Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam
RT @EricaWegrzyn: Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam
Oxycontin was submitted and justifiably approved by the agency as a 12 | JPR @DovePress https://t.co/fjzx1O9NUB
RT @EricaWegrzyn: Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam
Oxycontin was submitted and justifiably approved by the agency as a 12-hour dosage form, https://t.co/93wxCvAPCI.
RT @EricaWegrzyn: Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam
Check out our #OxyContin article in JPR #openaccess https://t.co/2VcqHauxnx with @JeffreyFudin @menaraouf92 #whatateam